Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

BioMarin Reports Positive Phase 3 Results For VOXZOGO

(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) on Wednesday announced positive Phase 3 results for VOXZOGO (vosoritide) in children with hypochondroplasia, with the study meeting its primary endpoint and all secondary efficacy endpoints.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

BoG affirms 8 ± 2% inflation target

According to its July 2026 Monetary Policy Report (MPR), the Central Bank said this will be influenced by the upward revisions in utility tariffs, re-escalation of geopolitical tensions in the Middle East, and the potential impacts of heavy rains on the food supply chain present upside risks to the inflation outlook.

BoG affirms 8 ± 2% inflation target

According to its July 2026 Monetary Policy Report (MPR), the Central Bank said this will be influenced by the upward revisions in utility tariffs, re-escalation of geopolitical tensions in the Middle East, and the potential impacts of heavy rains on the food supply chain present upside risks to the inflation outlook.

Wall St indexes open lower as oil crosses US$100

[NEW YORK] The main US stock indexes opened lower on Wednesday (Sep 9) as oil prices surged past the market-sensitive US$100-a-barrelmark level...

  • Wall Street indexes open lower on September 9
  • Oil price surpasses $100 per barrel for first time since July
  • Tensions in Middle East drive market decline

Embracing Your Failures

Failures are part of a process that helps you grow. If you stop fighting and start learning, failures can become some of the most useful teachers you will ever have.

More from Wednesday 9 September →